Agape ATP Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Agape ATP Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.52M | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.32M | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | $1.43M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.86M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $1.02M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $3.45M | Jul 5, 2022 |
| FY2020 | Dec 31, 2019 | $429.4K | Mar 31, 2021 |
| FY2018 | Jun 30, 2018 | $487.0K | Sep 27, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.52M | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.32M | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | $1.43M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.86M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $1.02M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $3.43M | Jul 5, 2022 |
| FY2019 | Dec 31, 2019 | $429.4K | Mar 27, 2020 |
| FY2019 | Jun 30, 2019 | $1.55M | Mar 27, 2020 |
| FY2019 | Dec 31, 2018 | $685.3K | Mar 27, 2020 |
| FY2019 | Jun 30, 2018 | $487.0K | Mar 27, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $838.3K | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $759.1K | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | $936.6K | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.19M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $719.6K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $2.68M | Jul 5, 2022 |
| FY2020 | Dec 31, 2019 | $45.9K | Mar 31, 2021 |
| FY2019 | Jun 30, 2019 | $109.4K | Mar 27, 2020 |
| FY2019 | Dec 31, 2018 | $65.9K | Mar 27, 2020 |
| FY2019 | Jun 30, 2018 | $45.6K | Mar 27, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.28M) | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | ($2.47M) | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | ($2.10M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($1.69M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($2.52M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $354.8K | Jul 5, 2022 |
| FY2020 | Dec 31, 2019 | ($338.9K) | Mar 31, 2021 |
| FY2019 | Jun 30, 2019 | ($377.2K) | Mar 27, 2020 |
| FY2019 | Dec 31, 2018 | ($142.4K) | Mar 27, 2020 |
| FY2019 | Jun 30, 2018 | ($130.3K) | Mar 27, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.26M) | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | ($2.57M) | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | ($2.15M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($1.53M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($1.86M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($158.1K) | Jul 5, 2022 |
| FY2020 | Dec 31, 2019 | ($266.4K) | Mar 31, 2021 |
| FY2019 | Jun 30, 2019 | ($131.2K) | Mar 27, 2020 |
| FY2019 | Dec 31, 2018 | $2.9K | Mar 27, 2020 |
| FY2019 | Jun 30, 2018 | ($234.1K) | Mar 27, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $312.3K | Mar 27, 2020 |
| FY2019 | Jun 30, 2019 | $240.5K | Mar 27, 2020 |
| FY2019 | Dec 31, 2018 | $63.1K | Mar 27, 2020 |
| FY2019 | Jun 30, 2018 | $279.7K | Mar 27, 2020 |
| FY2018 | Jun 30, 2017 | $75.4K | Sep 27, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.41M) | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | ($2.73M) | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | ($2.00M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($811.7K) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($845.8K) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($558.0K) | Jul 5, 2022 |
| FY2020 | Dec 31, 2019 | ($113.9K) | Mar 31, 2021 |
| FY2019 | Jun 30, 2019 | ($667.1K) | Mar 27, 2020 |
| FY2019 | Dec 31, 2018 | ($76.6K) | Mar 27, 2020 |
| FY2019 | Jun 30, 2018 | ($348.0K) | Mar 27, 2020 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $4.0K | Jul 5, 2022 |
| FY2021 | Dec 31, 2020 | $4.7K | Jul 5, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.59M | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $3.24M | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | $5.74M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $2.79M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $4.72M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $7.21M | Jul 5, 2022 |
| FY2020 | Dec 31, 2019 | $4.34M | Mar 31, 2021 |
| FY2019 | Jun 30, 2019 | $4.65M | Mar 27, 2020 |
| FY2019 | Dec 31, 2018 | $5.20M | Mar 27, 2020 |
| FY2019 | Jun 30, 2018 | $5.13M | Dec 2, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.17M | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.31M | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | $1.36M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.23M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $1.41M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.29M | Jul 5, 2022 |
| FY2020 | Dec 31, 2019 | $84.0K | Mar 31, 2021 |
| FY2019 | Jun 30, 2019 | $71.4K | Mar 27, 2020 |
| FY2019 | Dec 31, 2018 | $241.8K | Mar 27, 2020 |
| FY2019 | Jun 30, 2018 | $29.8K | Dec 2, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.46M | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.93M | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | $4.37M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.54M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $3.31M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $5.92M | Jul 5, 2022 |
| FY2020 | Dec 31, 2019 | $4.25M | Mar 31, 2021 |
| FY2019 | Jun 30, 2019 | $4.58M | Mar 27, 2020 |
| FY2020 | Dec 31, 2018 | $4.96M | Mar 31, 2021 |
| FY2019 | Jun 30, 2018 | $5.10M | Mar 27, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($11.80M) | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | ($9.52M) | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | ($7.05M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($4.95M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($3.26M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($734.4K) | Jul 5, 2022 |
| FY2020 | Dec 31, 2019 | ($1.09M) | Mar 31, 2021 |
| FY2019 | Jun 30, 2019 | ($750.3K) | Mar 27, 2020 |
| FY2019 | Dec 31, 2018 | ($373.1K) | Mar 27, 2020 |
| FY2019 | Jun 30, 2018 | ($230.6K) | Dec 2, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $140.1K | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | $2.04M | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | $4.83M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.44M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $2.60M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $3.52M | Jul 5, 2022 |
| FY2020 | Dec 31, 2019 | $2.74M | Mar 31, 2021 |
| FY2019 | Jun 30, 2019 | $2.86M | Mar 27, 2020 |
| FY2019 | Dec 31, 2018 | $3.45M | Mar 27, 2020 |
| FY2019 | Jun 30, 2018 | $3.53M | Dec 2, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | (31) | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Jul 5, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | (31) | Apr 13, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 1, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.00M | Apr 13, 2026 |
| FY2025 | Dec 31, 2024 | 79,781 | Apr 13, 2026 |
| FY2024 | Aug 30, 2024 | 20 | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | 3.86M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 75.45M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 290.46M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 376.45M | Jul 5, 2022 |
| FY2020 | Dec 31, 2019 | 376.28M | Mar 31, 2021 |
| FY2019 | Jun 30, 2019 | 376.28M | Mar 27, 2020 |
| FY2019 | Dec 31, 2018 | 376.28M | Mar 27, 2020 |